Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...
OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
MUNICH, Sept. 14, 2023 /PRNewswire/ -- Intellias, a leading technology partner to automotive OEMs and suppliers, has become a Vector Certified Embedded Engineering Partner (CEEP). To achieve ...
SAN FRANCISCO--(BUSINESS WIRE)--Vector Capital, a leading private equity firm specializing in transformational investments in established technology businesses, and Cerium Technology, a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback